Neonatal Pressure Ulcer Prevention

Neonatal Network : NN
|January 24, 2016
PubMed

Insights

Pressure ulcers affect up to 27% of infants in intensive care units. Understanding infant-specific risk factors is crucial for effective prevention strategies in neonatal intensive care units (NICUs).

Area of Science:

  • Pediatrics
  • Critical Care Medicine
  • Dermatology

Background:

  • Pressure ulcers are a significant concern in pediatric intensive care units (ICUs), with incidence rates reaching up to 27%.
  • Neonatal intensive care units (NICUs) report pressure ulcer rates between 16-19%.
  • Ill and preterm newborns possess unique anatomic, physiologic, and developmental characteristics that increase their susceptibility to skin breakdown.

Purpose of the Study:

  • To highlight the risk factors contributing to pressure ulcer development in critically ill infants and children.
  • To present case studies illustrating these risk factors in neonatal populations.
  • To describe evidence-based best practices for preventing pressure ulcers in vulnerable pediatric patients.

Main Methods:

  • Review of incidence data from intensive care units and neonatal intensive care units.
  • Analysis of case studies focusing on ill and preterm newborns.
  • Synthesis of current literature on pressure ulcer prevention strategies.

Main Results:

  • High incidence rates of pressure ulcers confirmed in pediatric ICUs and NICUs.
  • Identification of specific infant-related factors (anatomic, physiologic, developmental) predisposing to skin breakdown.
  • Case studies effectively demonstrated the interplay of these risk factors.

Conclusions:

  • Pressure ulcer prevention in critically ill infants requires a tailored approach considering their unique vulnerabilities.
  • Implementing best practices is essential to mitigate the risk of skin breakdown in neonatal and pediatric intensive care settings.
  • Further research into targeted prevention interventions for high-risk infant populations is warranted.

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.5K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.0K
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
6.5K